Colorectal cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Colorectal cancer patients, pathologically confirmed as adenocarcinoma, mucinous adenocarcinoma, and signet ring cell carcinoma; 2) Patients with an expected survival period of = 6 months; 3) Individuals with a PHQ-9 Depression Scale score = 5 or a GAD-7 Anxiety Scale score>0; 4) At least one measurable lesion displayed by imaging examinations (PET-CT, CT, MRI); 5) Age = 18 years old and = 80 years old; 6) The patient has good compliance and is able to understand the situation of this study and sign an informed consent form.
Exclusion criteria
Exclusion criteria: 1) Merge primary tumors from other parts; 2) Individuals with significant impairment of heart, liver, kidney, or hematopoietic function; 3) Those who have not completed 4 cycles of chemotherapy or traditional Chinese medicine use; 4) Merge active tuberculosis or infected individuals; 5) Poor compliance and inability to complete the study; 6) Participated in other clinical trials within the past month; 7) Pregnant or lactating women.
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Overall survival;Quality of life;Traditional Chinese Medicine Syndrome Indicators;Immune function;The degree of emotional disorders in patients;Gut microbiota; | — |
Primary
| Measure | Time frame |
|---|---|
| Progression-free survival; | — |
Countries
China
Contacts
Shanghai University of Traditional Chinese Medicine Affiliated Shuguang Hospital Cancer Research Institute